Sherbrooke Park Advisers’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$114K Buy
24,325
+9,448
+64% +$44.1K 0.05% 449
2025
Q1
$81.7K Sell
14,877
-8,449
-36% -$46.4K 0.04% 530
2024
Q4
$79.1K Buy
+23,326
New +$79.1K 0.03% 690